117 related articles for article (PubMed ID: 28386107)
1. Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo.
Yokota A; Hirai H; Shoji T; Maekawa T; Okuda K
Leukemia; 2017 Dec; 31(12):2742-2751. PubMed ID: 28386107
[TBL] [Abstract][Full Text] [Related]
2. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice.
Million RP; Aster J; Gilliland DG; Van Etten RA
Blood; 2002 Jun; 99(12):4568-77. PubMed ID: 12036890
[TBL] [Abstract][Full Text] [Related]
3. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
[TBL] [Abstract][Full Text] [Related]
4. A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase.
Million RP; Harakawa N; Roumiantsev S; Varticovski L; Van Etten RA
Mol Cell Biol; 2004 Jun; 24(11):4685-95. PubMed ID: 15143164
[TBL] [Abstract][Full Text] [Related]
5. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.
Golub TR; Goga A; Barker GF; Afar DE; McLaughlin J; Bohlander SK; Rowley JD; Witte ON; Gilliland DG
Mol Cell Biol; 1996 Aug; 16(8):4107-16. PubMed ID: 8754809
[TBL] [Abstract][Full Text] [Related]
6. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells.
Lacronique V; Boureux A; Monni R; Dumon S; Mauchauffé M; Mayeux P; Gouilleux F; Berger R; Gisselbrecht S; Ghysdael J; Bernard OA
Blood; 2000 Mar; 95(6):2076-83. PubMed ID: 10706877
[TBL] [Abstract][Full Text] [Related]
7. Activation of the NF-kappaB pathway by the leukemogenic TEL-Jak2 and TEL-Abl fusion proteins leads to the accumulation of antiapoptotic IAP proteins and involves IKKalpha.
Malinge S; Monni R; Bernard O; Penard-Lacronique V
Oncogene; 2006 Jun; 25(25):3589-97. PubMed ID: 16434962
[TBL] [Abstract][Full Text] [Related]
8. MN1-TEL, the product of the t(12;22) in human myeloid leukemia, immortalizes murine myeloid cells and causes myeloid malignancy in mice.
Carella C; Bonten J; Rehg J; Grosveld GC
Leukemia; 2006 Sep; 20(9):1582-92. PubMed ID: 16810199
[TBL] [Abstract][Full Text] [Related]
9. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
Mysliwiec T; Perego R; Kruh GD
Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
[TBL] [Abstract][Full Text] [Related]
10. A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation.
Iijima Y; Ito T; Oikawa T; Eguchi M; Eguchi-Ishimae M; Kamada N; Kishi K; Asano S; Sakaki Y; Sato Y
Blood; 2000 Mar; 95(6):2126-31. PubMed ID: 10706884
[TBL] [Abstract][Full Text] [Related]
11. Haemopoietic transformation by the TEL/ABL oncogene.
Hannemann JR; McManus DM; Kabarowski JH; Wiedemann LM
Br J Haematol; 1998 Jul; 102(2):475-85. PubMed ID: 9695962
[TBL] [Abstract][Full Text] [Related]
12. Signal transduction and cellular functions of the TEL/ARG oncoprotein.
Okuda K; Oda A; Sato Y; Nakayama A; Fujita H; Sonoda Y; Griffin JD
Leukemia; 2005 Apr; 19(4):603-10. PubMed ID: 15729383
[TBL] [Abstract][Full Text] [Related]
13. Transformation of Ba/F3 cells and Rat-1 cells by ETV6/ARG.
Iijima Y; Okuda K; Tojo A; Tri NK; Setoyama M; Sakaki Y; Asano S; Tokunaga K; Kruh GD; Sato Y
Oncogene; 2002 Jun; 21(28):4374-83. PubMed ID: 12080468
[TBL] [Abstract][Full Text] [Related]
14. The TEL/ARG leukemia oncogene promotes viability and hyperresponsiveness to hematopoietic growth factors.
Okuda K; Sato Y; Sonoda Y; Griffin JD
Int J Hematol; 2004 Feb; 79(2):138-46. PubMed ID: 15005341
[TBL] [Abstract][Full Text] [Related]
15. MN1-TEL myeloid oncoprotein expressed in multipotent progenitors perturbs both myeloid and lymphoid growth and causes T-lymphoid tumors in mice.
Kawagoe H; Grosveld GC
Blood; 2005 Dec; 106(13):4278-86. PubMed ID: 16081688
[TBL] [Abstract][Full Text] [Related]
16. Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia.
Cuenco GM; Ren R
Oncogene; 2001 Dec; 20(57):8236-48. PubMed ID: 11781838
[TBL] [Abstract][Full Text] [Related]
17. Functional interaction between the c-Abl and Arg protein-tyrosine kinases in the oxidative stress response.
Cao C; Leng Y; Li C; Kufe D
J Biol Chem; 2003 Apr; 278(15):12961-7. PubMed ID: 12569093
[TBL] [Abstract][Full Text] [Related]
18. The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts.
Cazzaniga G; Tosi S; Aloisi A; Giudici G; Daniotti M; Pioltelli P; Kearney L; Biondi A
Blood; 1999 Dec; 94(12):4370-3. PubMed ID: 10590083
[TBL] [Abstract][Full Text] [Related]
19. Tel/PDGFRbeta induces stem cell differentiation via the Ras/ERK and STAT5 signaling pathways.
Dobbin E; Graham C; Corrigan PM; Thomas KG; Freeburn RW; Wheadon H
Exp Hematol; 2009 Jan; 37(1):111-121. PubMed ID: 19100521
[TBL] [Abstract][Full Text] [Related]
20. Non-receptor tyrosine kinases c-Abl and Arg regulate the activity of C/EBPbeta.
Li X; Liu X; Wang G; Zhu X; Qu X; Li X; Yang Y; Peng L; Li C; Li P; Huang W; Ma Q; Cao C
J Mol Biol; 2009 Aug; 391(4):729-43. PubMed ID: 19563810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]